Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Sign in with

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
07/12/2022

Archive: 07/12/2022

European cardiologists call for urgent action to prevent medical device shortages

The European Society of Cardiology (ESC), which represents more than 100,000 health care professionals, today urges EU health ministers to prevent a shortfall of essential medical devices for cardiovascular patients.

Dec 7, 2022

0

23

Expert comments on human health risks of current bird flu outbreak

As the world grapples with one of the largest recorded outbreaks of bird flu (H5N1 avian influenza) concerns have been raised in the media about the potential risks to human health and whether this is the next pandemic we ...

Dec 7, 2022

0

5

Heart attack on a chip shows how heart changes after the event

Researchers at the University of Southern California Alfred E. Mann Department of Biomedical Engineering have developed a "heart attack on a chip," a device that could one day serve as a testbed to develop new heart drugs ...

Dec 7, 2022

0

107

New receptor 'decoy' drug neutralizes COVID-19 virus and its variants

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug ...

Dec 7, 2022

0

540

Study examines hesitation toward potential changes to bowel cancer surveillance

As doctors and researchers discuss whether to push recommended bowel cancer colonoscopy surveillance intervals out beyond five years, new research has found those at a higher risk of the disease would likely need to be convinced ...

Dec 7, 2022

0

16

Study suggests the youngest children in class are being overmedicated for ADHD

Christine Strand Bachmann has led a study that includes all Norwegian children born between 1989 and 1998, a total of 488,000 people.

Dec 7, 2022

0

7

Heads or tails: What statistical models tell us about the probability of living beyond 110

The world's presumed oldest person, Kane Tanaka of Japan, died in April in her native country at the age of 119. Despite her spectacular longevity, she could not surpass the record set by France's Jeanne Calment 25 years ...

Dec 7, 2022

0

13

Netflix psychiatrist Phil Stutz says 85% of early therapy gains are down to lifestyle changes—is he right?

Jonah Hill's Netflix documentary, "Stutz," is an insightful journey into the mind of his therapist, renowned psychiatrist Phil Stutz. Hill delves into Stutz' model of care, creatively using visual depictions of key concepts ...

Dec 7, 2022

0

8

T-DXd yields superior outcomes over chemotherapy-based regimens in patients previously treated with T-DM1

Compared with capecitabine-based regimens, trastuzumab deruxtecan (T-DXd) led to higher response rates and longer survival in the third-line setting for patients with HER2-positive metastatic breast cancer previously treated ...

Dec 7, 2022

0

4

SGLT-2i use before COVID-19 may reduce adverse outcomes in diabetes patients

For patients with diabetes subsequently diagnosed and hospitalized with COVID-19, use of a sodium-glucose cotransporter-2 inhibitor (SGLT-2i) before COVID-19 infection is associated with lower COVID-19-related adverse outcomes, ...

Dec 7, 2022

0

9

page 4 from 10

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2025 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us